Pipeline· June 13, 2026 · 15 min read
Topic
Novel Drug Approvals
Annual FDA novel drug approval reviews, first-in-class mechanisms, formulary impact, and mid-year access implications for new molecular entities.
Pipeline· June 13, 2026 · 12 min read
ClinicalTrials.gov by the numbers: 589K studies and a 58% Phase 3 results gap
Global· June 13, 2026 · 11 min read
What Canada approves: 13,428 drugs, generic DIN base, 89% domestic manufacturing
By Ran Chen#Health Canada#Biosimilars#Supply Chain
Approvals· June 11, 2026 · 10 min read
FDA Commissioner's National Priority Voucher program: what launch teams need to know
Approvals· June 10, 2026 · 10 min read
What the EU approves: 2,313 medicines, 29% oncology, 28 biosimilars in 2024
Approvals· May 26, 2026 · 8 min read
Novel FDA drug approvals Q1-Q2 2026: the fifteen drugs and their formulary implications
By Ran Chen#FDA Approval#Novel Drug Approvals#GLP-1